Compugroup Medical SE (COP) Given Consensus Rating of “Buy” by Analysts

Share on StockTwits

Shares of Compugroup Medical SE (ETR:COP) have received an average rating of “Buy” from the seven brokerages that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is €54.71 ($64.37).

A number of analysts recently commented on COP shares. Commerzbank set a €60.00 ($70.59) price target on Compugroup Medical and gave the stock a “buy” rating in a research note on Thursday, April 12th. Warburg Research set a €53.00 ($62.35) price target on Compugroup Medical and gave the stock a “buy” rating in a research note on Wednesday, April 25th. Baader Bank set a €49.00 ($57.65) price target on Compugroup Medical and gave the stock a “neutral” rating in a research note on Thursday, May 3rd. Berenberg Bank set a €49.00 ($57.65) price target on Compugroup Medical and gave the stock a “neutral” rating in a research note on Friday, May 4th. Finally, HSBC set a €57.00 ($67.06) price target on Compugroup Medical and gave the stock a “buy” rating in a research note on Friday, June 1st.

COP stock traded up €0.20 ($0.24) on Friday, reaching €48.60 ($57.18). The company’s stock had a trading volume of 50,173 shares, compared to its average volume of 68,245. Compugroup Medical has a 12-month low of €40.10 ($47.18) and a 12-month high of €60.30 ($70.94).

About Compugroup Medical

CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.

See Also: What is a closed-end mutual fund (CEF)?

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.